Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Peoples Bancorp Stock Rating and Price Targets Update

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Finances (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Alexander Twerdahl of Piper Sandler has upgraded Peoples Bancorp (NASDAQ: PEBO) to an Overweight rating, setting a Price Target of $34.

The average one-year price target for Peoples Bancorp Inc. currently stands at $35.292, with various forecasts ranging between $30.3 and $42.

In a previous update, Piper Sandler had raised Peoples Bancorp’s Price Target to $41 from $44, while maintaining an Overweight rating. However, there was a subsequent adjustment where Piper Sandler downgraded Peoples Bancorp to Neutral from Overweight, with a revised Price Target of $30 from $31.

As of February 23, 2024, these are the latest updates on Peoples Bancorp’s stock rating and price targets from Piper Sandler.

PEBO Stock Shows Positive Performance on February 23, 2024

On February 23, 2024, PEBO stock showed positive performance as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of PEBO shares increased by $0.22 since the market last closed, representing a 0.78% rise. The stock opened at $28.64, which was $0.29 higher than its previous close. Overall, PEBO stock had a strong start on February 23, 2024, with both price momentum and price change indicating positive performance. Investors may be optimistic about the company’s future prospects, leading to increased buying activity and driving the stock price higher. It is important for investors to continue monitoring PEBO stock performance and staying informed about any developments that may impact the stock price.

PEBO Stock Performance Analysis: Revenue and Net Income Increase, EPS Decrease

On February 23, 2024, PEBO stock showed mixed performances in terms of its financial indicators. According to data from CNN Money, the total revenue for PEBO was $526.82 million over the past year, which represented a 51.22% increase compared to the previous year. However, the total revenue for the last quarter was $149.38 million, which remained flat compared to the previous quarter.

The net income for PEBO was $112.56 million over the past year, reflecting an 11.62% increase compared to the previous year. The net income for the last quarter was $33.60 million, showing a 6.14% increase compared to the previous quarter.

In terms of earnings per share (EPS), PEBO reported $3.44 over the past year, which represented a 4.49% decrease compared to the previous year. The EPS for the last quarter was $0.96, which remained flat compared to the previous quarter.

Overall, while PEBO showed strong growth in total revenue and net income over the past year, there were some concerns regarding the decrease in EPS. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth prospects.

Tags: PEBO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Analysts Bullish on Ardelyx NASDAQ ARDX with Positive Price Targets

Biotechnology Markets and money

The Power of Compounded Returns A Case Study of CRISPR Therapeutics

Alternative Energy Stock Market Today (1)

Kosmos Energy Prepares for Quarterly Earnings Report What to Expect

Recommended

DrugRetailers Trading online

Introducing the Exclusive Collaboration AERIN x Pottery Barn Kids

2 years ago

Positive Options Trading Activity Indicates Bullish Outlook for Carnival Corporation

2 years ago

Analysts Upgrade Vertex Pharmaceuticals with Bullish Price Targets

2 years ago
Compass Stock

Compass Stock: Record Growth Defies Shrinking Market

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rare Earths Showdown: How China’s Export Curbs Fuel MP Materials’ Ascent

American Tower Faces Critical Test Ahead of Quarterly Earnings

Space Sector Surge Continues as Rocket Lab Gains Momentum

ZimVie Shareholders Approve Acquisition, Set for October Delisting

Chip Sector Reels as Trade Tensions Spark Selloff

Leadership Shakeup Rattles Nio’s Autonomous Driving Ambitions

Trending

CVS Health Stock
Analysis

Analyst Consensus Builds as CVS Health Receives Multiple Price Target Upgrades

by Felix Baarz
October 12, 2025
0

A notable alignment is emerging among major financial institutions regarding CVS Health, with several prominent investment banks...

Unitedhealth Stock

UnitedHealth Shares Tumble Despite Strong Quarterly Performance

October 12, 2025
IBM Stock

IBM Shares Approach Critical Technical Juncture

October 12, 2025
MP Materials Stock

Rare Earths Showdown: How China’s Export Curbs Fuel MP Materials’ Ascent

October 12, 2025
American Tower Stock

American Tower Faces Critical Test Ahead of Quarterly Earnings

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Analyst Consensus Builds as CVS Health Receives Multiple Price Target Upgrades
  • UnitedHealth Shares Tumble Despite Strong Quarterly Performance
  • IBM Shares Approach Critical Technical Juncture

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com